Note: Page numbers of article titles are in boldface type.
A
Acne, from lasers, 586, 588
Adverse events, from dermal fillers, 667
from neurotoxins, 664–665
prevention of, 666
Aesthetic expectations, difficult patient and, 579–580
preoperative discussion of, in facelift surgery, 552, 558
Aesthetic violations, from injectable fillers, 590–591
Aging, facial, preoperative assessment of, in facelift surgery, 552
Airway complications, from rhinoplasty, nasal obstruction as, 642, 649–650
Airway management, for facial cosmetic surgery, with conscious sedation, 566
with general anesthesia, for emergence, 569
for induction, 566–568
immediate recovery period, 569–570
Alar asymmetry, from rhinoplasty, of bony vault, 641, 647–648
of middle vault, 641, 647–648
Alar base scarring, from rhinoplasty, 642, 649
Alar cartilage, bossae of, from rhinoplasty, 641, 646–647
Alar retraction, from facial flap surgery, 600–601
from rhinoplasty, 641, 648–649
Alar rim grafts, in rhinoplasty, 641, 648–649
Alar-columellar disproportion, from rhinoplasty, 641–642, 648–649
Alcohol use, complications related to, in facial flap surgery, 600
Alfentanil, in facial cosmetic surgery, 565, 568
Allergic reactions, to dermal fillers, 667–670
prevention and treatment of, 669–670
to neurotoxins, 594–595
Alopecia, from facelift surgery, 557
from forehead lift, 623
Anesthesia, for facial cosmetic surgery, 560–571
blepharoplasty and, 571
burn injuries prevention and, 566–567
conscious sedation in, 564–567
intravenous opioids for, 564–566
successful, 566
dermal fillers and, 667
forehead lift and, 622
general anesthesia in, 566–570
airway management for, 566–568
emergence from, 569
hypotension control and, 568–569
immediate recovery period and, 569–570
induction and maintenance of, 568
pain control postoperative and, 568, 570
PONV and, 568–569
incidence of problems, 563–564
objectives of, 560–561
overview of, 560
patient positioning for, 563
patient safety for, essential requirements of, 560
patient selection and preparation in, 561–563
premedication and monitoring of, 563
procedure-related considerations of, 570–571
rhytidectomy and, 571
septorhinoplasty and, 570–571
strategies and methods of, 563–570
thromboembolism prophylaxis for, 563
for hair restoration, 679
Angle fractures, of mandible, 614–615
Antibody formation, to neurotoxins, 666
Anticoagulants, complications related to, in facial flap surgery, 600, 602–603
in facial trauma, 616
Antihelical malposition/puckering, from otoplasty, 660–661
Antihelical ridges, secondary to cartilage-scoring technique, in otoplasty, 659, 661
Asymmetry, of ala, from rhinoplasty, bony vault, 641, 647–648
middle vault, 641, 647–648
of brow, from forehead lift, 623
of face, in facelift surgery, 552, 557
of nasal tip, from rhinoplasty, 639–640, 643
of nostrils, from rhinoplasty, 641, 647–648
Atrophy, with mandibular fractures, 614–615
Auditory canal meatus, narrowing of external, from otoplasty, 660–662
Auricular composite grafts, in rhinoplasty, 641, 648–649
Auricular nerve injury, in facelift surgery, 554
Auricular proportions, normal, 653–654
Auricular ridges, secondary to cartilage-scoring technique, in otoplasty, 659, 661
Autospreader technique, in rhinoplasty, 645–646
B
Bleeding. See Hemorrhage.
Blepharoplasty, complications in, 625–637
anesthesia safety and, 571
assessment errors and, 625, 627–631
asymmetric eyelid crease as, 626, 629
brow ptosis as, 626, 630–631
canthal webbing as, 626, 630
eyelid ptosis as, 626–628
eyelid retraction/ectropion as, 626, 629–630
lagophthalmos as, 626, 630–632
residual skin excess as, 625–627
superior sulcus contour deformity/hollowing as, 626–629
introduction to, 625–627
summary overview of, 636
surgical, 631–636
corneal abrasion as, 627, 635
diplopia as, 626, 634
dissatisfied patient as, 627, 636
fire/burned skin/lashes as, 627, 635
hemorrhage as, 626, 631–632
horizontal eyelid phimosis as, 627, 635
inadvertent globe perforation as, 626, 631
lacrimal gland injury as, 626, 634–635
preseptal hematoma as, 626, 632
preseptal/orbital cellulitis as, 626, 633–634
retrobulbar hematoma as, 626, 632–633
suture granuloma as, 627, 636
wound dehiscence as, 627, 636
Blindness. See Vision disturbances/loss.
Blistering, from lasers, 586–587
Blood pressure, in facial cosmetic surgery, control of, 568–570
facial flaps and, 602–603
preoperative screening of, 561–562
Blood supply, of forehead, 620
complications with lift procedures, 622
Body dysmorphic disorder, rejecting patient with, 582
Body fractures, of mandible, 614–615
Bone injuries, in facial trauma, 606
fractures as, 607–608. See also Fractures.
with mandibular fractures, 614–615
BoNTA (botulinum toxin type A), 663. See also Neurotoxins.
Bony pyramid complications, from rhinoplasty, 640, 643–644
open roof deformity as, 640, 643–644
overresection of nasal bones as, 640, 643
rocker deformity as, 640, 643–644
stair step deformity as, 640, 644
Bony vault, of ala, asymmetry of, from rhinoplasty, 641, 647–648
Bossae, of tip and ala, from rhinoplasty, 641, 646–647
Botulinum-derived toxins. See also Neurotoxins.
in facial cosmetic surgery, 594–595, 663
pharmacology of, 663
Brain injuries, with facial trauma, intracranial complications of, 605–606, 609–610
types of, 609
Brow anatomy, in forehead lift, innervation, 620
muscles, 619–620
soft tissue, 619
vasculature, 620
Brow asymmetry, from forehead lift, 623
Brow lift, in forehead lift, complications in, 622–623
prevention of, 620–621
coronal, 621–622
direct, 621
endoscopic, 622
midforehead, 621
Brow position, ideal, 620–621
Brow ptosis, from blepharoplasty, 626, 630–631
from neurotoxins, 594–596
in forehead lift, 621
Bruising, from dermal fillers, 589–590, 667
from lasers, 586–587
from neurotoxins, 594–595, 664–665
prevention of, 666
Burns, in facial cosmetic surgery, from lasers, 586–587
prevention of, 566–567
of skin and lashes, from blepharoplasty, 627, 635
B
Bleeding. See Hemorrhage.
Blepharoplasty, complications in, 625–637
anesthesia safety and, 571
assessment errors and, 625, 627–631
asymmetric eyelid crease as, 626, 629
brow ptosis as, 626, 630–631
canthal webbing as, 626, 630
eyelid ptosis as, 626–628
eyelid retraction/ectropion as, 626, 629–630
lagophthalmos as, 626, 630–632
residual skin excess as, 625–627
superior sulcus contour deformity/hollowing as, 626–629
introduction to, 625–627
summary overview of, 636
surgical, 631–636
corneal abrasion as, 627, 635
diplopia as, 626, 634
dissatisfied patient as, 627, 636
fire/burned skin/lashes as, 627, 635
hemorrhage as, 626, 631–632
horizontal eyelid phimosis as, 627, 635
inadvertent globe perforation as, 626, 631
lacrimal gland injury as, 626, 634–635
preseptal hematoma as, 626, 632
preseptal/orbital cellulitis as, 626, 633–634
retrobulbar hematoma as, 626, 632–633
suture granuloma as, 627, 636
wound dehiscence as, 627, 636
Blindness. See Vision disturbances/loss.
Blistering, from lasers, 586–587
Blood pressure, in facial cosmetic surgery, control of, 568–570
facial flaps and, 602–603
preoperative screening of, 561–562
Blood supply, of forehead, 620
complications with lift procedures, 622
Body dysmorphic disorder, rejecting patient with, 582
Body fractures, of mandible, 614–615
Bone injuries, in facial trauma, 606
fractures as, 607–608. See also Fractures.
with mandibular fractures, 614–615
BoNTA (botulinum toxin type A), 663. See also Neurotoxins.
Bony pyramid complications, from rhinoplasty, 640, 643–644
open roof deformity as, 640, 643–644
overresection of nasal bones as, 640, 643
rocker deformity as, 640, 643–644
stair step deformity as, 640, 644
Bony vault, of ala, asymmetry of, from rhinoplasty, 641, 647–648
Bossae, of tip and ala, from rhinoplasty, 641, 646–647
Botulinum-derived toxins. See also Neurotoxins.
in facial cosmetic surgery, 594–595, 663
pharmacology of, 663
Brain injuries, with facial trauma, intracranial complications of, 605–606, 609–610
types of, 609
Brow anatomy, in forehead lift, innervation, 620
muscles, 619–620
soft tissue, 619
vasculature, 620
Brow asymmetry, from forehead lift, 623
Brow lift, in forehead lift, complications in, 622–623
prevention of, 620–621
coronal, 621–622
direct, 621
endoscopic, 622
midforehead, 621
Brow position, ideal, 620–621
Brow ptosis, from blepharoplasty, 626, 630–631
from neurotoxins, 594–596
in forehead lift, 621
Bruising, from dermal fillers, 589–590, 667
from lasers, 586–587
from neurotoxins, 594–595, 664–665
prevention of, 666
Burns, in facial cosmetic surgery, from lasers, 586–587
prevention of, 566–567
of skin and lashes, from blepharoplasty, 627, 635
C
Calcium hydroxylapatite fillers. See also Dermal fillers.
sequelae and complications of, 589–594
special characteristics of, 590, 667
Canthal webbing, from blepharoplasty, 626, 630
Cardiovascular disease, preoperative screening for, in facial cosmetic surgery, 561–562
Cardiovascular incidents, in facial cosmetic surgery, 563
Cartilage, alar, bossae of, from rhinoplasty, 641, 646–647
in auricular surgery, cutting vs. sparring techniques for, 653–654
necrosis of, 656
Cartilage grafts, in rhinoplasty, costal cartilage, 642, 650
for tip and ala, 614, 646–647
visible, 647
Cartilage-scoring technique, in otoplasty, antihelical ridges secondary to, 659, 661
Cellulitis, preseptal/orbital, from blepharoplasty, 626, 633–634
Cerebrospinal fluid (CSF) leaks, with facial trauma, 605–606, 609
Cervical spine injuries, with facial trauma, 605–606, 609–611
Chemotherapeutic agents, complications related to, in facelift surgery, 552
Chronic pain, difficulty in evaluating patient, 583
Close friends, difficulty in evaluating patient, 583
Cobblestoning, of recipient site, in hair restoration, 676
Columella complications, from rhinoplasty, retraction as, 642, 648–649
scar formation as, 642, 649
Comorbidities, multiple medical, rejecting patient with, 582
Complication prevention/management, from lasers, fillers, and neurotoxins, 585–598 . See also Lasers.
from toxins and fillers, 663–673 . See also Dermal fillers; Neurotoxins.
in blepharoplasty, 625–637 . See also Blepharoplasty.
in facelift surgery, 551–558 . See also Facelift surgery.
in facial cosmetic surgery. See also Facial cosmetic surgery.
patient selection and, 579–584 . See also Patient selection.
peri-operative and anesthesia-related, 559–577
in facial flap surgery, 599–604 . See also Facial flap surgery.
in facial trauma, 605–617 . See also Facial trauma.
in hair restoration, 675–680 . See also Hair restoration.
of forehead lift, 619–624 . See also Forehead lift.
of otoplasty, 653–662 . See also Otoplasty.
of rhinoplasty, 639–651 . See also Rhinoplasty.
Compression of grafts, at recipient site, in hair restoration, 676–677
Compressive dressings, in facelift surgery, 555
in facial flap surgery, 603
in otoplasty, 655
Computed tomography (CT) scan, for facial trauma, 616
lower face, 614–615
upper face, 608
Computer imaging, in patient selection, 580
Concha-mastoid suture, in otoplasty, 660–662
Condyle fractures, of mandible, 614–615
Conscious sedation, in facial cosmetic surgery, 564–567
intravenous opioids for, 564–566. See also specific medication.
successful, 566
Contour deformities, from facelift surgery, 557
of nasal tip, from rhinoplasty, 641, 647
of superior sulcus, from blepharoplasty, 626–629
Corneal abrasion, from blepharoplasty, 627, 635
Coronal lift, in forehead lift, 621–622
Correction loss (recurrence), in otoplasty, 657–658
Corrugator supercilii muscles, in forehead lift, 619–620
coronal approach and, 621
endoscopic approach and, 622
neurotoxins and, 666
Costal cartilage grafts, complications of, in rhinoplasty, 642, 647, 650
Cupid’s bow flattening, from neurotoxins, 595–596
D
Deformity patient, minor, difficulty in evaluating, 582
Delayed union, of mandibular fractures, 614–615
Dentition injuries, in facial trauma, 606
with mandibular fractures, 614–615
Depressed patient, difficulty in evaluating, 582
Dermal fillers, in facial cosmetic surgery, 585–598
background on, 666–667
common adverse events from, 667
common available products as, 589–590
complications from, 589–594, 663–673
aesthetic violations as, 590–591
blindness as, 590, 592, 594
bruising as, 589–590
common adverse events vs., 667
cosmetic, 670
edema as, 589–591
erythema as, 589–590
granuloma as, 590–592
hypersensitivity reactions to, 667–670
prevention and treatment of, 669–670
infection as, 590–591
laser technologies sequelae vs., 585–589
lumpiness as, 590–593
necrosis as, 590, 592–594, 667–669
recognition and treatment of, 668
neurotoxin sequelae vs., 594–596, 663–666
Tyndall effect as, 590–593, 670
contraindications to, 667
for small depressions/divots, 584
introduction to, 585
summary overview of, 589–590, 596, 670
Dexmedetomidine, in facial cosmetic surgery, 565–566
Diabetes mellitus, preoperative assessment of, in facial cosmetic surgery, 562
Difficult patients, challenges in evaluating, 582–583
recognizing, for complication avoidance, 579–584
Diplopia, from blepharoplasty, 626, 634
Direct brow lift, in forehead lift, 621
Disliked patients, rejecting, 581
Dissatisfied patient, how to manage, 580, 583–584
with blepharoplasty, 627, 636
with otoplasty, 658, 660
Doctor shoppers, difficulty in evaluating, 582–583
Doctor-patient relationship, patient selection and, 579–580
“Done look,” of rhytidectomy, 558
Donor site, in hair restoration, procedural approach to, 679
surgical assistant duties for, 680
surgical complications of, necrosis as, 675–676
pain as, 675–676
scarring as, 675–676
Dorsal reduction, cartilaginous, in rhinoplasty, dorsal narrowing from, 645–646
Dressings, Glasscock, in otoplasty, 655
postoperative. See Compressive dressings.
Dry eyes, from neurotoxins, 665
Dyschromia, from lasers, 586, 588–589
Dysphagia, from neurotoxins, 595–596
Dysphonia, from neurotoxins, 595–596
E
Ears, normal aesthetics of, 653–654
otoplasty complications of, 653–662 . See also Otoplasty.
Ecchymosis. See Bruising.
Ectropion, from blepharoplasty, 626, 629–630
from facial flap surgery, 601
from facial trauma, 611, 613
from neurotoxins, 666
Edema, from dermal fillers, 589–591, 667
treatment of, 668
from facial flap surgery, 602
from lasers, 586–587
from neurotoxins, 594–595, 664
Elderly patients, anesthesia considerations for, in facial cosmetic surgery, 562
Endoscopic brow lift, in forehead lift, 622
Endotracheal tube (ETT), 566, 569
Enophthalmos, from facial trauma, 612–613
Entrapment, periorbital, from facial trauma, 611–613
Entropion, from facial trauma, 611, 613
Epidermolysis, from facial flap surgery, 602
Erb’s point, in facelift incisions, 554–555
Erythema, from dermal fillers, 589–590, 667
from facial flap surgery, 603
from lasers, 586–587
from neurotoxins, 594–595, 664
from otoplasty, 655–656
Esmolol, in facial cosmetic surgery, 568
External auditory canal meatus, narrowing of, from otoplasty, 660–662
Eye evaluation, in forehead lift, 621
Eye injuries. See also Vision disturbances/loss.
in facial trauma, 606, 608, 610–611
Eyelash burns, from blepharoplasty, 627, 635
Eyelid crease, asymmetric, from blepharoplasty, 626, 629
Eyelid ptosis, from blepharoplasty, 626–628
from neurotoxins, 595–596, 665
Eyelids, eversion of. See Ectropion.
in forehead lift, 621
injuries of, from facial trauma, 608, 611, 613
phimosis of, horizontal, from blepharoplasty, 627, 635
retraction of, from blepharoplasty, 626, 629–630
Eyes, dry, from neurotoxins, 665
F
Facelift surgery, complication avoidance and management in, 551–558
“done look” and, 558
intraoperative, 553–555
auricular nerve injury as, 554
facial nerve branch injury as, 554
immediate postoperative procedures for, 555
incision and flap dissection for, 553–555
jowl liposuction for, 555
parotid duct injury as, 553
positioning and preparation for, 553
skin excision and wound closure for, 555
SMAS plication for, 555
spinal accessory nerve injury as, 554–555
introduction to, 551–553
postoperative, 555–557
alopecia as, 557
contour deformities as, 557
hematoma as, 555
infection as, 556
nerve injury as, 556
scarring as, 556
skin slough as, 556
systemic complications as, 556
preoperative avoidance of, 551–552
summary overview of, 557–558
Facial aging, preoperative assessment of, in facelift surgery, 552
Facial asymmetry, in facelift surgery, as postoperative complication, 557
preoperative assessment of, 552
Facial cosmetic surgery, complication prevention in, 559–577
anesthetic management for, 560–571
blepharoplasty and, 571
burn injuries prevention in, 566–567
conscious sedation in, 564–567
intravenous opioids for, 564–566. See also specific medication.
successful, 566
general anesthesia in, 566–570
airway management for, 566–568
emergence from, 569
hypotension control and, 568–569
immediate recovery period and, 569–570
induction and maintenance of, 568
pain control postoperative and, 568, 570
PONV and, 568–569
incidence of problems, 563–564
objectives of, 560–561
overview of, 560
patient positioning in, 563
patient selection and preparation in, 561–563
premedication and monitoring in, 563
procedure-related considerations in, 570–571
rhytidectomy and, 571
septorhinoplasty and, 570–571
strategies and methods of, 563–570
thromboembolism prophylaxis in, 563
general considerations of, 559–560
perioperative risk reduction guidelines as, 560, 570
solutions to identified problems as, 560
structural recommendations as, 560
surgical safety checklists as, 560–561
patient selection and, 579–584
anesthesia considerations in, 561–562
computer imaging and, 580
difficult evaluations, 582–583
easy rejections, 581–582
fee policy discussions, 580–581
introduction to, 579–580
revision surgery policy discussions, 580–581
summary overview of, 584
techniques for learning more about patients, 580–581
unhappiness handling, 580, 583–584
perioperative management for, 560–563
patient preparation in, 562–563
patient selection in, 561–562
risk reduction essentials, 560, 570
procedure-related. See specific procedure or technique.
summary overview of, 571
Facial fillers. See Dermal fillers.
Facial flap surgery, complications in, 599–604
hematologic, 602–603
infectious, 603
introduction to, 599
ischemic, 601–602
patient evaluation for, 599–600
summary overview of, 603
tension-related, 600–601
Facial nerve, in forehead lift, 620, 622–623
preoperative assessment of, in facelift surgery, 552
Facial nerve injuries, in facelift surgery, 554
in facial trauma, 608, 612
Facial trauma, complications in, 605–617 . See also specific anatomy or injury.
introduction to, 605
lower third of face, 608, 614–615
management of, 614–616
intraoperative, 614
perioperative, 614
postoperative, 614–616
preoperative, 614
middle third of face, 607–608, 611–614
most common, 605–608
of soft tissue, 605–606, 608
of viscera, 605–606, 608–610, 612
pharmacologic, 616
summary overview of, 616
upper third of face, 607–608
Family members, difficulty in evaluating patient, 583
Fee policy, discussions of, in patient selection, 580–581
Fillers. See Dermal fillers.
Fires, on-patient, prevention in operating room, 566–567
skin and lash burns from, in blepharoplasty, 627, 635
Flap dissection, in facelift surgery, 553–555
Flap surgery. See Facial flap surgery.
Flexible laryngeal mask airway (FLMA), 567, 569
Forehead anatomy, 619–620
Forehead lift, complications of, 619–624
alopecia as, 623
anatomy in, 619–620
brow innervation, 620
brow muscles, 619–620
brow soft tissue, 619
brow vasculature, 620
bleeding as, 622
brow asymmetry as, 623
brow lift complications in, 622–623
introduction to, 619
nerve injury as, 622–623
over elevation as, 623
patient history in, 620
physical examination in, 620–621
prevention of, 620–621
scarring as, 622–623
summary overview of, 623
types of, 621–622
coronal lift, 621–622
direct brow lift, 621
endoscopic brow lift, 622
midforehead lift, 621
under elevation as, 623
Fractures, from facial trauma. See also specific anatomy.
lower face, 608, 614–616
middle face, 607–608, 612, 614
upper face, 607–608
Frontal sinus fracture, from facial trauma, 607–608
Frontalis muscle, in forehead lift, 619–620
coronal approach and, 621